bpc-157 human studies safety fda warning 10 questions to ask your doctor about peptides bpc-157 human clinical trials evidence

Receptor Binding: Specific CNS Binding Sites Tritium-labelled Semax binding studies in rat basal forebrain have identified high-affinity, specific CNS binding sites with a KD of 2.4 1.0 nM and a BMAX of 33.5 7.9 fmol/mg protein pharmacological parameters consistent with a specifically acting compound at dedicated receptor sites rather than non-specific membrane interactions

A good clinical question is not: Do peptides grow hair? A better question is: Which peptide, at what dose, with which delivery method, in which type of hair loss, compared with which treatment, and measured over how many months? That is where the field still needs work

Some patients may experience temporary irritation at the injection site

Non-FOB orders under $70 are subject to a $7.00 shipping fee